Recombinant SARS Coronavirus antigen (37 kDa), contains a mosaic of the immunodominant regions of the C-terminal of the Spike protein and a GST fusion partner, was expressed in Ecoli, and puried in vitro using Metal affinity chromatography techniques.
Nature
Recombinant
Tag/Conjugate
GST
Molecular Weight
37 kDa
Alternative Names
SARS Spike Protein; SARS; SARS S Protein; SARS Spike; SARS S
Purity
> 95% pure (10% PAGE, coomassie staining). GS-4B Sepharose-Affinity Purification.
The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto. protein E is a kinesin-like motor protein that accumulates in the G2 phase of the cell cycle. Unlike other centromere-associated proteins, it is not present during interphase and first appears at the centromere region of chromosomes during prometaphase. CENPE is proposed to be one of the motors responsible for mammalian chromosome movement and/or spindle elongation.
Keywords
SARS Spike Protein; SARS; SARS S Protein; SARS Spike; SARS S
Citations
Have you cited DAG539 in a publication? Let us know and earn a reward for your research.
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Recombinant SARS Spike Protein (C-terminal) [GST]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.